Sweden | Researchers at Uppsala University have developed a new PET imaging method that could significantly improve the diagnosis of brain diseases, including Alzheimer’s.The technique, known as “pretargeted PET,” allows scientists to visualize disease-related proteins in the brain more effectively. Traditional PET methods face challenges because antibodies struggle to cross the blood-brain barrier and require long-lasting radioactive substances, which can expose patients to radiation for extended periods.The new approach solves this by separating the process into two steps. First, a specially modified antibody is introduced into the brain and allowed time to bind to its target, such as amyloid beta—a protein strongly linked to Alzheimer’s disease. In a second step, a small radioactive molecule is injected, which attaches to the antibody using a method known as click chemistry, enabling rapid and precise imaging.This innovation reduces unnecessary radiation exposure while improving imaging accuracy. The researchers successfully demonstrated the method in experimental models, marking an important proof of concept.Importantly, the technique is not limited to Alzheimer’s disease. Scientists believe it could be applied to detect other brain conditions, including tumors and neuroinflammatory diseases, where current diagnostic tools are limited.Further research will focus on improving imaging contrast and testing the method on additional disease targets, bringing it closer to clinical application.
Source: Uppsala University
#WordMain #StudentNewsPortal #Europe #studentnews
About the Author
